Search for: "Endo Pharmaceuticals Inc."
Results 1 - 20
of 136
Sorted by Relevance
|
Sort by Date
28 Feb 2014, 8:09 am
Endo Pharmaceuticals Pays Settlement for Off-Label Marketing of Lidoderm Pain Patch Endo Health Solutions Inc and its subsidiary Endo Pharmaceuticals have agreed to pay $171.9 million to settle False Claims allegations for off-label marketing of their pain patch, Lidoderm. [read post]
16 Sep 2021, 12:57 pm
Suffolk and Nassau Counties will each receive $13.85 million in combined settlements from Endo and its subsidiary Par Pharmaceutical, Inc. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
24 Feb 2014, 8:37 am
According to DOJ’s press release: Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
7 Oct 2024, 5:35 pm
According to DOJ’s press release: Endo Health Solutions Inc. [read post]
18 Jan 2022, 2:29 pm
” Upon paying the settlement amount, Endo and two of its subsidiaries, Endo Pharmaceuticals Inc. and Endo Health Solutions Inc., will fully resolve Florida’s pending opioid-related claims. [read post]
16 May 2019, 8:15 am
See Endo Pharms., Inc. v. [read post]
6 Apr 2014, 10:00 pm
In Endo Pharmaceuticals, Inc. v. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
10 Jun 2019, 10:59 am
Slatery III has filed suit against Endo Pharmaceuticals and Endo Health Solutions Inc. [read post]
5 Feb 2014, 9:21 am
Endo Pharmaceuticals Inc. v. [read post]
4 Jul 2011, 9:59 pm
Endo Pharmaceuticals Inc. v. [read post]
9 Jan 2009, 8:21 pm
By Jason Derry --Endo to Acquire Indevus On January 5, 2009, Endo Pharmaceuticals Holdings Inc. announced that it will buy Indevus Pharmaceuticals Inc. for an initial payment of about $370 million and an additional $267 million, based on certain milestones. [read post]
10 Jun 2010, 9:46 pm
By James DeGiulio -- Endo Settles with Impax and Sandoz in Opana Patent Suits Endo Pharmaceuticals Inc. has settled patent infringement suits against Sandoz Inc. and Impax Laboratories Inc. over generic versions of painkiller Opana ER. [read post]
8 Oct 2016, 3:25 am
Andrews, following a bench trial, in Endo Pharmaceuticals Inc. et al. v. [read post]
29 Aug 2006, 11:50 am
Patent and Trademark Office about the painkiller's effectiveness thus giving Endo Pharmaceutical Holdings Inc. the right to sell a generic version. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
13 Jun 2010, 9:35 pm
Paddock Laboratories Inc. 1:10-cv-00501; filed June 9, 2010 in the District Court of Delaware • Plaintiffs: Allergan Inc.; Allergan USA Inc.; Allergan Sales LLC; Endo Pharmaceuticals Solutions Inc.; Supernus Pharmaceuticals Inc. [read post]
20 May 2015, 1:00 am
Wall Street Journal, Rules Fail To Rein In Tax-Driven Takeovers: Endo International PLC agreed to buy rival drug maker Par Pharmaceutical Holdings Inc. for $8 billion, the latest in a string of cross-border mergers steering tax revenue away from the U.S., despite Washington’s efforts. [read post]
18 Aug 2022, 11:39 am
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
